Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.54 |
| ▸ | PKM | P14618 | 1/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | APEX1 | P27695 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | KMO | O15229 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | PTGS1 | P23219 | 4/20 | 0.39 |
| ▸ | PTGS2 | P35354 | 4/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethylene Glycol SCHEMBL3521345 | 0.94 | ALDH1A1 (0.48) | ALDH1A1PKMMAPK1HSD17B10CYP1A2 | |
| SCHEMBL5200032 | 0.91 | ALDH1A1 (0.50) | ALDH1A1PKMMAPK1HSD17B10CYP1A2 | |
| SCHEMBL501046 | 0.86 | PTGS1 (0.50) | ALDH1A1MAPK1HSD17B10CYP1A2SMN1; SMN2 | |
| SCHEMBL7463384 | 0.85 | PTGS1 (0.58) | ALDH1A1PKMHSD17B10POLBSMN1; SMN2 | |
| SCHEMBL27248010 | 0.83 | PTGS1 (0.61) | ALDH1A1PKMHSD17B10POLBSMN1; SMN2 | |
| SCHEMBL7259687 | 0.83 | PTGS1 (0.61) | ALDH1A1PKMHSD17B10POLBSMN1; SMN2 | |
| SCHEMBL5697933 | 0.83 | PTGS1 (0.61) | ALDH1A1PKMHSD17B10POLBSMN1; SMN2 | |
| SCHEMBL5698003 | 0.83 | PTGS1 (0.61) | ALDH1A1PKMHSD17B10POLBSMN1; SMN2 | |
| SCHEMBL1618771 | 0.83 | PTGS1 (0.61) | ALDH1A1PKMHSD17B10POLBSMN1; SMN2 | |
| SCHEMBL5698008 | 0.83 | PTGS1 (0.61) | ALDH1A1PKMHSD17B10POLBSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1922 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3689898-B1 | LONG-ACTING CONJUGATE OF GLUCAGON-LIKE PEPTIDE-2 (GLP-2) DERIVATIVE | HANMI PHARMACEUTICAL CO LTD (KR) | 2026-04-29 | — | — | EP | claimed |
| WO-2025202864-A1 | ENT1 INHIBITORS IN COMBINATION WITH ONCOLYTIC VIRUSES AND THEIR USE IN THE TREATMENT OF CANCER | iTeos Belgium SA (BE) | 2025-10-02 | — | — | WO | claimed |
| WO-2025126110-A1 | ENT1 INHIBITORS IN COMBINATION WITH BISPECIFIC ANTIBODIES | iTeos Belgium SA (BE) | 2025-06-19 | — | — | WO | claimed |
| CN-120041114-A | High-viscosity composite binder and preparation method thereof | 长园新能源材料研究院(广东)有限公司 | 2025-05-27 | — | — | CN | claimed |
| WO-2025104613-A1 | ENT1 INHIBITORS IN COMBINATION WITH CHECKPOINT INHIBITORS | iTeos Belgium SA (BE) | 2025-05-22 | — | — | WO | claimed |
| EP-3782653-B1 | COMPOSITION COMPRISING PEGYLATED ARGININE DEIMINASE | POLARIS GROUP (TW) | 2025-03-19 | — | — | EP | claimed |
| CN-119529003-A | Albumin-binding doxorubicin prodrug, self-assembled nanoparticle thereof and application thereof | 沈阳药科大学 | 2025-02-28 | — | — | CN | claimed |
| CN-118027176-B | Human beta 2-microglobulin mutant | 郑春杨 | 2024-12-24 | — | — | CN | claimed |
| EP-4005590-B1 | METHODS AND COMPOSITIONS FOR MODULATING THE IMMUNE SYSTEM WITH ARGINASE I | BIO CANCER TREAT INTERNATIONAL LTD (CN) | 2024-12-04 | — | — | EP | claimed |
| EP-3389696-B1 | AMELIORATING SYSTEMIC SCLEROSIS WITH DEATH RECEPTOR AGONISTS | UNIV JOHNS HOPKINS (US) | 2024-11-27 | — | — | EP | claimed |
| EP-1206252-A1 | AMPLIFICATION OF FOLATE-MEDIATED TARGETING TO TUMOR CELLS USING POLYMERS | BIOTECH AUSTRALIA PTY. LIMITED (AU) | 2002-05-22 | — | — | EP | claimed |
| US-6348558-B1 | OLIGOMERS COMPRISING ALKYLENE OXIDE MONOMERS AND CARBONATE LINKAGES; POLYCARBONATEETHER COPOLYMERS; DRUG DELIVERY; CONJUGATED TO PEPTIDES OR PROTEINS FOR REDUCED IMMUNOGENICITY; STABILITY | SHEARWATER CORPORATION | 2002-02-19 | — | — | US | claimed |
| EP-0366041-B2 | Imido-percarboxylic acids | AUSIMONT SPA (IT) | 2001-09-12 | — | — | EP | claimed |
| WO-2000066091-A1 | AMPLIFICATION OF FOLATE-MEDIATED TARGETING TO TUMOR CELLS USING POLYMERS | BIOTECH AUSTRALIA PTY LIMITED (AU) | 2000-11-09 | — | — | WO | claimed |
| US-6093541-A | WITH METAL PRESENTATION SURFACE HAVING IMMOBILIZED COMPLEX OF TETHERING MOLECULE AND DIGESTION MOLECULE; FOR RAPID AND EFFICIENT ANALYSIS OF BIOMOLECULES USING MATRIX-ASSISTED LASER DESORPTION/IONIZATION TECHNIQUE | ARIZONA STATE UNIVERSITY BOARD OF REGENTS (US) | 2000-07-25 | — | — | US | claimed |
| EP-0366041-B1 | Imido-percarboxylic acids | AUSIMONT SPA (IT) | 1998-08-05 | — | — | EP | claimed |
| CN-1059562-A | Reduce the method for carryover contamination in the amplification procedure | AMGEN INC (US) | 1992-03-18 | — | — | CN | claimed |
| US-RE32868-E | Antihyperlipidemic compositions | RESEARCH CORPORATION (US) | 1989-02-14 | — | — | US | claimed |
| US-4608246-A | Testing for a blood group immunological reaction | IMMUCOR, INC. (US) | 1986-08-26 | — | — | US | claimed |
| US-4395417-A | Antihyperlipidemic compositions | RESEARCH CORPORATION (US) | 1983-07-26 | — | — | US | claimed |